[go: up one dir, main page]

ES8103970A1 - Pharmaceutical composition containing dihydroergotoxine - Google Patents

Pharmaceutical composition containing dihydroergotoxine

Info

Publication number
ES8103970A1
ES8103970A1 ES491455A ES491455A ES8103970A1 ES 8103970 A1 ES8103970 A1 ES 8103970A1 ES 491455 A ES491455 A ES 491455A ES 491455 A ES491455 A ES 491455A ES 8103970 A1 ES8103970 A1 ES 8103970A1
Authority
ES
Spain
Prior art keywords
dihydroergotoxine
pharmaceutical composition
coating
composition containing
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES491455A
Other languages
Spanish (es)
Other versions
ES491455A0 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Original Assignee
Sanofi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi SA filed Critical Sanofi SA
Publication of ES491455A0 publication Critical patent/ES491455A0/en
Publication of ES8103970A1 publication Critical patent/ES8103970A1/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Pharmaceutical compositions contain dihydroergotoxine and comprise non-toxic carrier particles provided with a coating of a mixture containing dihydroergotoxine, said coating being covered with a coating of a methacrylic acid polymer, a poly(alkylmethacrylate) or a mixture of these polymers have sustained/delayed release properties.
ES491455A 1979-04-26 1980-04-25 Pharmaceutical composition containing dihydroergotoxine Expired ES8103970A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7910620A FR2454804B1 (en) 1979-04-26 1979-04-26 DIHYDROERGOTOXIN-BASED MEDICINAL PRODUCT AND PROCESS FOR PREPARING THE SAME

Publications (2)

Publication Number Publication Date
ES491455A0 ES491455A0 (en) 1981-04-16
ES8103970A1 true ES8103970A1 (en) 1981-04-16

Family

ID=9224784

Family Applications (1)

Application Number Title Priority Date Filing Date
ES491455A Expired ES8103970A1 (en) 1979-04-26 1980-04-25 Pharmaceutical composition containing dihydroergotoxine

Country Status (6)

Country Link
BE (1) BE882913A (en)
ES (1) ES8103970A1 (en)
FR (1) FR2454804B1 (en)
GB (1) GB2048671B (en)
IL (1) IL59764A (en)
IT (1) IT1130109B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4411882A (en) 1978-12-21 1983-10-25 Sandoz Ltd. Galenical compositions
FR2534139B1 (en) * 1982-10-07 1986-08-29 Laruelle Claude NOVEL GALENIC FORM OF SULPIRIDE, METHOD FOR PREPARING SAME, AND MEDICINAL PRODUCT COMPRISING THIS NEW FORM
FR2539995B1 (en) * 1983-01-28 1985-08-16 Sanofi Sa PROGRAMMED RELEASE MEDICINE BASED ON ACETYLSALICYLIC ACID
FR2539989B1 (en) * 1983-01-28 1985-08-09 Sanofi Sa PROGRAMMED RELEASE MEDICINE COMBINING ACETYLSALICYLIC ACID WITH DIHYDROERGOTAMINE
FR2554718B1 (en) * 1983-11-14 1986-04-04 Ethypharm Sa NEW ORAL SULPIRIDE FORMS FOR SULPIRIDE
FR2556964A1 (en) * 1983-12-23 1985-06-28 Ile De France NEW GALENIC FORMS OF SULPIRIDE USED ORALALLY
US5069911A (en) * 1985-02-05 1991-12-03 Sandoz Ltd. Pharmaceutical 9,10-dihydrogenated ergot alkaloid containing compositions
NZ286242A (en) * 1991-03-26 1997-11-24 Csl Ltd Use of veterinary implant as a single dose vaccination system: rupturable polymer film coating around core of active agent and water soluble excipient
CN102266310B (en) * 2011-07-21 2014-01-15 佛山市隆信医药科技有限公司 Dihydroergotoxine mesylate sustained-release capsule and preparation method thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1347413A (en) * 1963-01-29 1963-12-27 Italnysco S P A Broad-acting spherules or globules and method for their preparation
GB1175430A (en) * 1966-04-07 1969-12-23 Sandoz Ltd Pharmaceutical Compositions containing Ergot Alkaloids
DE2010416B2 (en) * 1970-03-05 1979-03-29 Hoechst Ag, 6000 Frankfurt Orally applicable dosage form with sustained release effect
DE2336218C3 (en) * 1973-07-17 1985-11-14 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Oral dosage form
DE2546577B2 (en) * 1975-10-17 1981-04-02 Sandoz-Patent-GmbH, 7850 Lörrach Solid substances made from polyvinylpyrrolidone and ergot alkaloids
LU77353A1 (en) * 1977-05-16 1979-01-19

Also Published As

Publication number Publication date
BE882913A (en) 1980-08-18
ES491455A0 (en) 1981-04-16
FR2454804B1 (en) 1986-11-21
IT8067531A0 (en) 1980-04-04
IL59764A (en) 1984-06-29
GB2048671A (en) 1980-12-17
FR2454804A1 (en) 1980-11-21
IT1130109B (en) 1986-06-11
IL59764A0 (en) 1980-06-30
GB2048671B (en) 1983-07-13

Similar Documents

Publication Publication Date Title
JPS5436359A (en) Preparation of polyolefin film
GR852158B (en)
HU9401850D0 (en) Pharmaceutical compositions containing nifedipine and process for the preparation thereof
WO1998022097A3 (en) Controlled release matrix composition using polar polymer or monomer and poly(acrylic acid) blend
EP0415302A3 (en) Graft polymers with unsaturated side chains, light sensitive compositions containing them and coating composition with these polymers
ES8103970A1 (en) Pharmaceutical composition containing dihydroergotoxine
DE3373417D1 (en) Use of a sulfonated homo- or copolymer of styrene for the manufacture of a contraceptive composition
PT87404A (en) PROCESS FOR THE PREPARATION OF AN ADDITIVE FOR THE FIRE EXTINCTION WATER CONTAINING HIGH POLYMERS
JPS5486530A (en) Coating powder composition
ES2173337T3 (en) PLASTISOL COMPOSITIONS.
DE2860978D1 (en) Process for the preparation of a low molecular weight acrylate copolymer, and a liquid coating composition having a high solids content based on the acrylate copolymer thus obtained
TW430559B (en) Particulate carriers and pharmaceutical compositions containing the same
ES8100881A1 (en) Naftidrofuryl composition for immediate and delayed release
AU552567B2 (en) Oligopeptides with specific inhibiting properties of collageninduced aggregation, process for preparing the same and pharmaceutical compositions containing them
HU9400954D0 (en) Granulated composition based on peroxidized derivatives which may be used for bleaching hair and process for the preparation of the said composition
ES8106925A1 (en) Powdery coating materials and their use.
JPS54119585A (en) Production of polymer composition containing physiologically active substance
ES8802396A1 (en) Coating composition for dosage forms
JPS57109848A (en) Polyolefin resin composition
ES464489A1 (en) Coating compositions
JPS5274623A (en) Coating composition having excellent adhesivity with polyethylene
JPS5767678A (en) Hot-melt adhesive composition
JPS5361636A (en) Water-soluble high polymer compositions
JPS54131636A (en) Hot-melt pressure-sensitive adhesive composition
ZA821613B (en) Polymeric material containing randomly distributed hydroxyl groups from polymers and copolymers of conjugated dienes,process for the preparation thereof,and use thereof